Glosid (Carbocisteine Lysine)

Glosid is indicated for the management of respiratory disorders in which viscous mucus impairs airway clearance. It may be used as part of a broader treatment plan for chronic and acute conditions that produce excessive or thick sputum.

• Chronic bronchitis with productive cough.
• Chronic obstructive pulmonary disease (COPD) exacerbations.
• Asthma with mucus hypersecretion.
• Acute respiratory tract infections featuring thick sputum.
• Post‑operative or post‑traumatic airway clearance where mucus is tenacious.

The safety profile of Glosid includes both frequently observed and less common adverse reactions.

Common

• Mild gastrointestinal discomfort such as nausea or dyspepsia.
• Transient abdominal cramps or loose stools.
• Slight headache or dizziness.
• Dry mouth or altered taste sensation.
• Mild skin rash or pruritus.
• Transient mild fever.
• Occasional mild constipation.
• Temporary increase in sputum production.
• Mild insomnia.
• Transient visual disturbances.
• Mild fatigue.

Serious

• Severe allergic reactions including angioedema or anaphylaxis.
• Persistent vomiting or diarrhea leading to dehydration.
• Hepatic dysfunction indicated by elevated liver enzymes.
• Bronchospasm or worsening respiratory symptoms.
• Blood dyscrasias such as neutropenia.
• Renal impairment manifested by reduced urine output.
• Cardiac arrhythmia in susceptible patients.

When prescribing Glosid, clinicians should evaluate patient history and monitor for conditions that may increase the risk of adverse outcomes.

• Assess for known hypersensitivity to carbocisteine or any excipients before initiating therapy.
• Use caution in patients with active peptic ulcer disease or severe gastrointestinal disorders.
• Monitor liver function tests periodically in individuals with pre‑existing hepatic impairment.
• Evaluate renal function, especially in elderly patients, as dose adjustment may be required.
• Consider potential bronchospasm in asthmatic patients; discontinue if respiratory symptoms worsen.
• Avoid use during acute severe asthma attacks without medical supervision.
• Discuss pregnancy and lactation status with the patient, as safety data are limited.

Glosid may interact with other medicines, altering its effectiveness or increasing the risk of side effects.

Avoid

• Concomitant use with potent oxidizing agents that may degrade carbocisteine.
• Combination with other mucolytic agents, which can lead to excessive thinning of mucus.

Use with caution

• Antitussive medications, as reduced cough reflex may impair mucus clearance.
• Bronchodilators, because altered mucus properties could affect drug deposition.
• Antibiotics that are excreted renally, requiring monitoring of renal function.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs), due to potential gastrointestinal irritation.